Dupilumab for cancer-associated refractory pruritus.
Talmon A, Elias S, Rubin L, Ribak Y, Ben Dori E, Shamriz O, Lotem M, Adini I, Tal Y.
Talmon A, et al. Among authors: shamriz o.
J Allergy Clin Immunol Glob. 2023 Jun 23;2(3):100128. doi: 10.1016/j.jacig.2023.100128. eCollection 2023 Aug.
J Allergy Clin Immunol Glob. 2023.
PMID: 37779518
Free PMC article.